|
Raymond Allen Dwek CBE FRS FRSC (born 10 November 1941) is a scientist at the University of Oxford and founder of the biotechnology company Oxford GlycoSciences Ltd.〔(Enemy of disease, friend of Israel, Jerusalem Post )〕 ==Biography== Raymond Dwek was educated at Carmel College, then the University of Manchester where he studied Chemistry (1960–64). He then went to Lincoln College, Oxford, where he completed his DPhil in Physical Chemistry in 1966. He is a Professorial Fellow of Exeter College, Oxford and Director of the Oxford Glycobiology Institute, which he founded in 1991. From 2000-06 he was also Head of the Department of Biochemistry. He is a member of the Board of Scientific Governors at The Scripps Research Institute. Dwek is President of the Institute of Biology, Scientific Advisor to the President of Ben-Gurion University of the Negev in Israel and the Institute of Biochemistry in Bucharest. ==Academic and scientific career== Dwek was educated at the University of Manchester where he read Chemistry (1960–64) He completed his DPhil in Physical Chemistry at Oxford in 1966. Following this, he became a Research Lecturer at Christ Church where he taught Physical and Inorganic Chemistry. In 1969 he was invited to join the Biochemistry Department, working with other members of the Oxford Enzyme Group. In 1974 he was elected Royal Society Locke Research fellow, working on antibodies. This led to his appointment as University Lecturer in Biochemistry with a Fellowship, by special election, at Exeter College in 1976. At the same time, he was also appointed a Lecturer in Biochemistry at Trinity College to help build up the subject there. In 1988, Raymond Dwek was made Director of the Glycobiology Institute and became Professor of Glycobiology. Also in 1988, he was the founding scientist and non-executive director of Oxford GlycoSciences Plc (formerly Oxford GlycoSystems), which was established to commercialise technologies arising from research at the Glycobiology Institute. In 1995 the company was mentioned as part of the Queen's Anniversary Prize to the University of Oxford. In 1998 it was publicly quoted on the London Stock Exchange. In 1998, Dwek became founding scientist and chairman of the Scientific Board and Director of Synergy, which was established in the USA to develop antiviral agents for the treatment of chronic Hepatitis B and C infections. This work was taken over by United Therapeutics, USA and Professor Dwek became a Director of this company. The company sponsors the antiviral laboratory at the Glycobiology Institute and the Annual Virology Lecture in the department. Dwek is the author of Nuclear Magnetic Resonance (NMR) in biochemistry - application to enzyme systems (OUP, 1973), Principles and Problems in Physical Chemistry for Biochemists, with N C Price (OUP, 1974) and Biology Spectroscopy with I D Campbell (Benjamin Cummings, 1984). 抄文引用元・出典: フリー百科事典『 ウィキペディア（Wikipedia）』 ■ウィキペディアで「Raymond Dwek」の詳細全文を読む スポンサード リンク
|